EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,954,000 | +41.4% | 836,802 | +48.2% | 6.97% | +75.0% |
| Q1 2021 | $4,917,000 | -51.3% | 564,555 | -39.3% | 3.98% | -48.3% |
| Q4 2020 | $10,105,000 | -15.5% | 930,467 | -7.2% | 7.70% | -18.4% |
| Q3 2020 | $11,960,000 | -16.4% | 1,002,528 | +12.5% | 9.44% | -5.8% |
| Q2 2020 | $14,314,000 | +14.2% | 891,277 | -0.3% | 10.02% | -18.8% |
| Q1 2020 | $12,539,000 | -47.2% | 893,698 | -7.4% | 12.34% | -22.5% |
| Q4 2019 | $23,752,000 | – | 965,519 | – | 15.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |